COVID-19 might be the biggest pandemic the world has seen in a century, but it’s not the first major pandemic or epidemic. Ebola, H1N1 influenza, SARS, MERS and Zika all have rocked the news cycle in recent years, with long-lasting ramifications on global health, infrastructure and economies in the 21st century. The disease that develops from the SARS-CoV-2 virus won’t be the last, or possibly even the biggest to come.
During such epidemics, scientific research has been published in a rapid flurry. As on-the-ground, immediately clinically relevant research is published, other researchers look to the past — digging into the pathogen’s etiology — while others steadfastly focus on the future to develop treatments and vaccines.
While looking into the past, present and future of an outbreak, other trends in the research inevitably emerge. For example, Zika led to an explosion of research into identifying and tracking long-term sequelae of prenatal exposure to a Zika infection and will likely lead to research into effective interventions for these children. The current pandemic may lead to the exploration of faster, more effective testing due to the various missteps that occurred in the U.S.
To explore these spheres more deeply, Elsevier Research Intelligence is hosting a webinar at 11 a.m. ET on Monday, March 30, that examines insights and trends into collaborative infectious disease outbreak research. While the webinar is aimed primarily at scientists and researchers, journalists likely will learn valuable insights to help direct their coverage of this outbreak in real-time and the subsequent flood of research to come.
The webinar is free and available to view after it initially airs, but viewers must register in advance. Elsevier says the event will cover:
- Trending topics and top research organizations working to strengthen our understanding of infectious outbreak research,
- How the research was conducted to uncover the impact and trends of the outbreaks, and trends and
- Practical examples of how Scopus and SciVal were used to analyze the scholarly output.
In the meantime, while waiting for the webinar with all that free time (ha!) that you have while hopefully reporting from home, check out Elsevier’s Novel Coronavirus Information Center for all their journals’ open-access research on the coronavirus and COVID-19.